ORIGINAL PAPER
Increased serum vaspin concentration in full-term neonates with early-onset infections
More details
Hide details
1
Department of Neonatal Intensive Care, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Zabrze, Poland
2
Department of Paediatrics in Zabrze, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Zabrze, Poland
Submission date: 2019-06-10
Final revision date: 2019-07-09
Acceptance date: 2019-07-16
Publication date: 2019-08-30
Pediatr Pol 2019;94(4):235-240
KEYWORDS
TOPICS
ABSTRACT
Aim of the study:
The evaluation of serum vaspin concentration (SVC) in full-term, appropriate for gestational age (AGA) neonates, according to their sex, gestational age, anthropometric parameters, type of delivery, birth asphyxia, and kind of infection.
Material and methods:
In 183 full-term neonates, 102 infected and 81 healthy, 108 male and 75 female, 119 born vaginally and 64 by caesarean section, SVC was measured in serum of peripheral venous blood by ELISA test between the third and seventh day of life. The study was approved by the Ethics Committee of the Medical University of Silesia in Katowice. The neonates were divided into two groups: group I – 102 infected; and group II (control) – 81 healthy full-term neonates from physiological pregnancies. Early-onset infection involved sepsis (24 cases), bilateral pneumonia (38 cases), urinary tract infection (24 cases), purulent omphalitis, dermatitis, purulent meningitis, and osteomyelitis.
Results:
In infected neonates the SVC ranged from 0.093 to 1.19 ng/ml, and in the control group from 0.018 to 0.580 ng/ml. It was stated that infected neonates have significantly (p < 0.002) higher SVC than healthy neonates. Septic neonates had the highest value, significantly higher than local infected neonates. We did not observe any differences between infected males and females, or between those born by caesarean section and those delivered vaginally. Healthy girls had significantly higher SVC than the healthy boys. No correlation was noted between SVC and anthropometric parameters in both healthy and infected neonates and between sex, birth asphyxia, and C-reactive protein value in infected babies.
Conclusions:
Early-onset infections, especially sepsis, increase SVC in full-term, AGA neonates independently of their sex, birth asphyxia, and type of delivery.
REFERENCES (33)
1.
Liu L, Oza S, Hogan D, et al. Global, regional and national causes of child mortality in 2000-13 with projections to inform post 2015 priorities: an updated systematic analysis. Lancet 2015; 385: 430-440.
2.
Simonsen KA, Anderson-Berry Al, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev 2014; 27: 21-47.
3.
Khan AM, Morris SK, Bhutta ZA. Neonatal and perinatal infections. Pediatr Clin North Am 2017; 64: 7985-798.
4.
Shane AL, Sanches PJ, Stoll BJ. Neonatal sepsis. Lancet 2017; 390: 1770-1780.
5.
Kan B, Razzaghian HR, Lavoie PM. An immunological perspective on neonatal sepsis. Trends Mol Med 2016; 22: 290-302.
6.
Iroh Tam PY, Bendel CM. Diagnostics for neonatal sepsis: current approaches and future directions. Pediatr Res 2017; 82: 574-583.
7.
Bohanon FJ, Nunez Lopez O, Adhikari D, et al. Race, income and insurance status affect neonatal sepsis mortality and healthcare resource utilization. Pediatr Infect Dis J 2018; 37: 178-184.
8.
Cailes B, Kortsalioudaki C, Buttery J, et al. Epidemiology of UK neonatal infections: the neonIN infection surveillance network. Arch Dis Child Fetal Neonatal Ed 2018; 103: F547-F553.
9.
Alves JB, Gabani FL, Ferrari RAP, et al. Neonatal sepsis: mortality in municipality in southern Brazil, 2000-2013. Rev Paul Pediatr 2018; 36: 132-140.
10.
Wiśniewska-Ulfik D, Godula-Stuglik U, Szymańska A, et al. Wpływ wczesnych zakażeń na stężenie adiponektyny i leptyny w surowicy noworodków donoszonych. Pediatr Pol 2017; 92: 242-251.
11.
Gad GI, Ismail RI, El-Masry SA, et al. Serum apelin in early-onset neonatal sepsis: it is diagnostic. J Neonatal Perinatal Med 2014; 7: 207-212.
12.
Sadownik B, Lukas W, Behrendt J, et al. An analysis of factors determining serum leptin concentrations in healthy and infected newborns. Neuroendocrinol Lett 2010; 31: 221-228.
13.
Stojewska M, Wnęko-Masłoń B, Nawrat A, et al. Stężenie rezystyny w surowicy noworodków donoszonych z zakażeniami wewnątrzmacicznymi. Pediatr Pol 2016; 91: 325-331.
14.
Wiśniewska-Ulfik D, Godula-Stuglik U, Wąsek-Buko M, et al. Zmiany stężeń waspiny i leptyny w surowicy noworodków donoszonych z wrodzonym zapaleniem płuc. Pediatr Pol 2017; 92: 252-259.
15.
Akcay A, Akar M, Demirel G, et al. Umbilical cord and fifth-day serum vaspin concentrations in small-, appropriate- and large-for-gestational age neonates. J Pediatr Endocrinol Metab 2013; 26: 635-638.
16.
Briana DD, Boutsikou M, Baka S, et al. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism 2011; 60: 486-490.
17.
Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease inhibitor. A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005; 102: 10610-10615.
18.
Li Q, Chen R, Moriya J, Yamakawa J, et al. A novel adipokine, visceral adipose tissue-derived serine protease inhibitor (vaspin and obesity). J Int Med Res 2008; 36: 625-629.
19.
Li K, Li L, Yang M, et al. Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity. Eur J Endocrinol 2011; 164: 905-910.
20.
Zhou X, Chen Y, Yao Y, et al. Serum vaspin as a predictor of adverse cardiac events in acute myocardial infarction. J Am Heart Assoc 2019; 22: e010934.
21.
Buyukinan M, Atar M, Can U, et al. The association between serum vaspin and omentin-1 levels in obese children with metabolic syndrome. Metab Syndr Relat Disord 2018; 16: 76-81.
22.
Breifeld J, Wiele N, Gutsmann B, et al. Circulating adipokine vaspin is associated with serum lipid profiles in humans Lipids 2019; 54: 203-210.
23.
KÖrner A, Neef M, Friebe D, et al. Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 2011; 35: 578-586.
24.
Grzelak T, Tyszkiewicz-Nwafor M, Dutkiewicz A, et al. Neuropeptide B and vaspin as new biomarkers in anorexia nervosa. BioMed Res Int 2018; 2018: 9727509.
25.
Zhang Y, Chen RM, Lin XQ, et al. The correlation between serum adipokines levels and metabolic indicators in girls with Turner syndrome. Cytokine 2019; 113: 139-143.
26.
Szczepańska M, Machura E, Adamczyk P, et al. Evaluation of adipocytokines in children with chronic kidney disease. Endokrynol Pol 2015; 66: 100-107.
27.
Mierzyński R, Poniedziałek-Czajkowska E, Dłuski D, et al. Nesfatin-1 and vaspin as potential novel biomarkers for the prediction and early diagnosis of gestational diabetes mellitus. Int J Mol Sci 2019; 20: E159.
28.
Hernández-Rodríguez CE, Estrada Zúńiga CM, De la O-Cavazos ME, et al. Vaspin, a compensatory mechanism against high glucose levels since birth. J Clin Res Pediatr Endocrinol 2019; 11: 125-131.
29.
Kafalidis G, Boutsikou T, Briana DD, et al. Adipokines vaspin and omentin-1 are up-regulated in large for gestational age infants at term. Cytokine 2013; 62: 70-74.
30.
Motal MC, Klaus DA, Lebherz-Eichinger D, et al. Increased plasma vaspin concentration in patient with sepsis: an exploratory examination. Biochem Med (Zagreb) 2015; 25: 90-96.
31.
Ballard JL, Koury JC, Wedig K, et al. New Ballard score, expanded to include extremely premature infants. J Pediatr 1991; 119: 417-423.
32.
Lauterbach R. ABC zakażeń u noworodków. In: Neonatologia (2nd ed.), Szczapa J (ed.). Warszawa 2015: 295-306.
33.
Koiou E, Kalaitzakis E, Tziomalos K, et al. Vaspin: a novel adipokine, member of the family of serine protease inhibitors. Aristole University Medical Journal 2011; 38: 7-18.